Etorica MR Tablet is a combination medication containing Etoricoxib 60mg and Thiocolchicoside 4mg, designed to provide effective relief from pain and inflammation associated with musculoskeletal conditions. Etoricoxib, a selective COX-2 inhibitor, works by reducing the production of prostaglandins responsible for inflammation and pain, offering targeted anti-inflammatory and analgesic effects with a lower risk of gastrointestinal side effects compared to non-selective NSAIDs. Thiocolchicoside is a muscle relaxant that acts on the central nervous system to alleviate muscle spasms and stiffness, enhancing mobility and comfort. Together, these components provide a synergistic effect, making Etorica MR suitable for managing acute musculoskeletal pain, including lower back pain, osteoarthritis, and soft tissue injuries. The modified-release formulation ensures sustained drug release, maintaining consistent therapeutic levels and improving patient compliance by reducing dosing frequency. Etorica MR should be used under medical supervision, especially in patients with a history of cardiovascular disease, gastrointestinal disorders, or hepatic impairment. Common side effects may include gastrointestinal discomfort, dizziness, or allergic reactions. It is contraindicated in patients with hypersensitivity to its components or severe renal impairment. Always follow the prescribed dosage and consult a healthcare professional before use.